Ren Yamada

768 total citations
22 papers, 270 citations indexed

About

Ren Yamada is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Ren Yamada has authored 22 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 10 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Ren Yamada's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Ren Yamada is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Ren Yamada collaborates with scholars based in Japan, United Kingdom and Netherlands. Ren Yamada's co-authors include Masahiro Hiratsuka, Taiki Sato, Hiroto Hayashi, Noriyasu Hirasawa, Siddhartha Das, Takuya Sho, Koji Ogawa, Masato Nakai, Naoya Sakamoto and Kenichi Morikawa and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Ren Yamada

20 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ren Yamada Japan 9 94 89 89 75 35 22 270
Dolgormaa Gantumur Japan 9 102 1.1× 149 1.7× 133 1.5× 96 1.3× 40 1.1× 13 336
Alix Bruneau Germany 8 71 0.8× 102 1.1× 72 0.8× 88 1.2× 29 0.8× 15 259
Suchira Gallage Germany 8 114 1.2× 118 1.3× 42 0.5× 27 0.4× 24 0.7× 10 273
Mitsuko Hara Japan 8 103 1.1× 105 1.2× 108 1.2× 28 0.4× 17 0.5× 10 250
José M. Ramos Pittol Netherlands 11 173 1.8× 127 1.4× 75 0.8× 181 2.4× 37 1.1× 19 415
Mirella Pastore Italy 9 111 1.2× 163 1.8× 148 1.7× 87 1.2× 56 1.6× 21 396
Myeong‐Jin Nam South Korea 7 233 2.5× 130 1.5× 65 0.7× 41 0.5× 33 0.9× 8 392
Helena Degroote Belgium 11 86 0.9× 71 0.8× 91 1.0× 66 0.9× 46 1.3× 30 309
Shunsuke Shiba Japan 10 59 0.6× 118 1.3× 95 1.1× 28 0.4× 67 1.9× 14 253
H Soliman France 9 115 1.2× 64 0.7× 60 0.7× 66 0.9× 8 0.2× 19 326

Countries citing papers authored by Ren Yamada

Since Specialization
Citations

This map shows the geographic impact of Ren Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren Yamada more than expected).

Fields of papers citing papers by Ren Yamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ren Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren Yamada. The network helps show where Ren Yamada may publish in the future.

Co-authorship network of co-authors of Ren Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Ren Yamada. A scholar is included among the top collaborators of Ren Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ren Yamada. Ren Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuoka, Wataru, et al.. (2025). Mathematical Framework to Identify Optimal Molecule Based on Virtual Ligand Strategy. Journal of Chemical Information and Modeling. 65(13). 6913–6926.
2.
Yamada, Ren, et al.. (2024). Annulation Producing Diverse Heterocycles Promoted by Cobalt Hydride. ACS Catalysis. 14(20). 15514–15520. 5 indexed citations
3.
Matsuoka, Wataru, Ren Yamada, Shin‐ichi Suda, et al.. (2024). Virtual Ligand-Assisted Optimization: A Rational Strategy for Ligand Engineering. ACS Catalysis. 14(21). 16297–16312. 2 indexed citations
4.
Nakai, Masato, Kenichi Morikawa, Takashi Sasaki, et al.. (2023). Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis. Journal of Gastroenterology. 58(7). 656–667.
5.
6.
Nakai, Masato, Goki Suda, Koji Ogawa, et al.. (2022). Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients. PLoS ONE. 17(7). e0270786–e0270786. 5 indexed citations
7.
Suzuki, Kazuharu, Goki Suda, Yoshiya Yamamoto, et al.. (2022). Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B. PLoS ONE. 17(1). e0261760–e0261760. 20 indexed citations
8.
Nakai, Masato, Kenichi Morikawa, Akinori Kubo, et al.. (2022). Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma. World Journal of Hepatology. 14(7). 1480–1494. 3 indexed citations
9.
Nakai, Masato, Yoshiya Yamamoto, Masaru Baba, et al.. (2022). Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication. Scientific Reports. 12(1). 1449–1449. 15 indexed citations
10.
Sho, Takuya, Kenichi Morikawa, Akinori Kubo, et al.. (2021). Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy. World Journal of Gastrointestinal Oncology. 13(12). 2076–2087. 4 indexed citations
11.
Kawagishi, Naoki, Goki Suda, Megumi Kimura, et al.. (2021). Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C. Scientific Reports. 11(1). 9207–9207. 8 indexed citations
12.
Kubo, Akinori, Goki Suda, Megumi Kimura, et al.. (2021). Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI. Cancers. 13(14). 3633–3633. 9 indexed citations
13.
Suda, Goki, Megumi Kimura, Osamu Maehara, et al.. (2021). Changes in the estimated renal function after hepatitis C virus eradication with direct‐acting antiviral agents: Impact of changes in skeletal muscle mass. Journal of Viral Hepatitis. 28(5). 755–763. 5 indexed citations
14.
Shigesawa, Taku, Goki Suda, Megumi Kimura, et al.. (2021). Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma. PLoS ONE. 16(3). e0247728–e0247728. 3 indexed citations
15.
Nakai, Masato, Goki Suda, Akinori Kubo, et al.. (2020). Durable response without recurrence to Tolvaptan improves long-term survival. Journal of Gastroenterology. 55(12). 1150–1161. 1 indexed citations
16.
Kawagishi, Naoki, Goki Suda, Megumi Kimura, et al.. (2020). High serum angiopoietin‐2 level predicts non‐regression of liver stiffness measurement‐based liver fibrosis stage after direct‐acting antiviral therapy for hepatitis C. Hepatology Research. 50(6). 671–681. 16 indexed citations
17.
Shigesawa, Taku, Goki Suda, Megumi Kimura, et al.. (2020). Baseline angiopoietin‐2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma. JGH Open. 4(5). 880–888. 9 indexed citations
18.
Hirasawa, Noriyasu, Siddhartha Das, Hiroto Hayashi, et al.. (2014). Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose. Diabetes Metabolic Syndrome and Obesity. 7. 185–185. 18 indexed citations
19.
Hayashi, Hiroto, Ren Yamada, Siddhartha Das, et al.. (2014). Glucagon-like peptide-1 production in the GLUTag cell line is impaired by free fatty acids via endoplasmic reticulum stress. Metabolism. 63(6). 800–811. 37 indexed citations
20.
Nishizawa, Satoshi, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.. (2012). HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem–like Cells. Cancer Research. 72(11). 2844–2854. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dolgormaa Gantumur Breakdown of academic impact, for papers by Alix Bruneau Breakdown of academic impact, for papers by Suchira Gallage Breakdown of academic impact, for papers by Mitsuko Hara Breakdown of academic impact, for papers by José M. Ramos Pittol Breakdown of academic impact, for papers by Mirella Pastore Breakdown of academic impact, for papers by Myeong‐Jin Nam Breakdown of academic impact, for papers by Helena Degroote Breakdown of academic impact, for papers by Shunsuke Shiba Breakdown of academic impact, for papers by H Soliman
Rankless by CCL
2026